Oxidative Stress and Gut-Derived Lipopolysaccharides in Neurodegenerative Disease: Role of NOX2
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Background. Neurodegenerative diseases (ND) as Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis represent a growing cause of disability in the developed countries. The underlying physiopathology is still unclear. Several lines of evidence suggest a role for oxidative stress and NADPH oxidase 2 (NOX2) in the neuropathological pathways that lead to ND. Furthermore, recent studies hypothesized a role for gut microbiota in the neuroinflammation; in particular, lipopolysaccharide (LPS) derived from Gram-negative bacteria in the gut is believed to play a role in causing ND by increase of oxidative stress and inflammation. The aim of this study was to assess NOX2 activity as well as serum 8-iso-prostaglandin F2α (8-iso-PGF2α), serum H2O2, and LPS in patients with ND compared to controls. Methods. One hundred and twenty-eight consecutive subjects, including 64 ND patients and 64 controls (CT) matched for age and gender, were recruited. A cross-sectional study was performed to compare serum activity of soluble NOX2-dp (sNOX2-dp), blood levels of isoprostanes, serum H2O2, and LPS in these two groups. Serum zonulin was used to assess gut permeability. Results. Compared with CT, ND patients had higher values of sNOX2-dp, 8-iso-PGF2α, H2O2, and LPS. Simple linear regression analysis showed that sNOX2-dp was significantly correlated with serum LPS ( Rs=0.441 ; p<0.001 ), zonulin ( Rs=0.411 ; p<0.001 ), serum H2O2 ( Rs=0.329 ; p<0.001 ), and 8-iso-PGF2α ( Rs=0.244 ; p=0.006 ). LPS significantly correlated with serum zonulin ( Rs=0.818 ; p<0.001 ) and 8-iso-PGF2α ( Rs=0.280 ; p=0.001 ). A multiple linear regression analysis was performed to define the independent predictors of sNOX2-dp. LPS (SE, 0.165; standardized coefficient β, 0.459; p<0.001 ) and 8-iso-PGF2α (SE, 0.018; standardized coefficient β, 0.220; p=0.005 ) emerged as the only independent predictive variables associated with sNOX2-dp ( R2=57% ). Conclusion. This study provides the first report attesting that patients with ND have high NOX2 activation that could be potentially implicated in the process of neuroinflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“LPS is elevated in both the blood and brain of AD patients.25–29”
From TET2-mutant myeloid cells mitigate Alzheimer’s disease progression via CNS infiltration and enhanced phagocytosis in mice (2025) · cites this paper as [26]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This condition, known as intestinal permeability or leaky gut, has been implicated in the pathophysiology of various GI, as well as extraintestinal disorders [120,121,122], including PD [117,123,124,125,126,127,128]”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [127]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living
Lawton, M. P., & Brody, E. M. (1969) · The Gerontologist · doi:10.1093/geront/9.3_part_1.179 · Cited by 18,540
Katz, S. (1963) · JAMA · doi:10.1001/jama.1963.03060120024016 · Cited by 2,421
Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration
Qin, L., Wu, X., Block, M. L., Liu, Y., Breese, G. R., Hong, J., Knapp, D. J., & Crews, F. T. (2007) · Glia · doi:10.1002/glia.20467 · Cited by 2,144 · cited 1×
“Animal studies showed that systemic LPS administration increases neuroinflammation and leads to progressive neurodegeneration [13, 33].”
BackgroundGut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease
Pickard, J. M., Zeng, M. Y., Caruso, R., & Núñez, G. (2017) · Immunological Reviews · doi:10.1111/imr.12567 · Cited by 1,699 · cited 1×
“In human, the gut microbiota plays pivotal functions as intestinal epithelial barrier protection, immune homeostasis, immune responses (as induction of T cell-dependent and independent production of IgA antibodies, promotion of mucosal Th17 cell response and IL-10 from intestinal macrophages), and protection against p…”
BackgroundBrain-Gut-Microbiota Axis in Alzheimer’s Disease
Kowalski, K., & Mulak, A. (2019) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm18087 · Cited by 826
Microbiota-Brain-Gut Axis and Neurodegenerative Diseases
Quigley, E. M. M. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0802-6 · Cited by 804 · cited 2×
“In particular, lipopolysaccharide (LPS) derived from Gram-negative bacteria is believed to play a role in causing ND by increase of oxidative stress and inflammation [12, 13].”
BackgroundOxidative Stress in Neurodegenerative Diseases
Niedzielska, E., Smaga, I., Gawlik, M., Moniczewski, A., Stankowicz, P., Pera, J., & Filip, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9337-5 · Cited by 800 · cited 1×
“Growing evidences demonstrated that oxidative stress plays a pivotal role in the initiation and progression of ND [2].”
BackgroundIsoprostanes: markers and mediators of oxidative stress
Montuschi, P., Barnes, P. J., & Roberts, L. J. (2004) · The FASEB Journal · doi:10.1096/fj.04-2330rev · Cited by 747
Fasano, A., Not, T., Wang, W., Uzzau, S., Berti, I., Tommasini, A., & Goldblum, S. E. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02169-3 · Cited by 670
Cited by
Interrelation between ROS and Ca2+ in aging and age-related diseases
Madreiter-Sokolowski, C. T., Thomas, C., & Ristow, M. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101678 · Cited by 365
Ferro, D., Baratta, F., Pastori, D., Cocomello, N., Colantoni, A., Angelico, F., & Del Ben, M. (2020) · Nutrients · doi:10.3390/nu12092762 · Cited by 191
The endotoxin hypothesis of Alzheimer’s disease
Brown, G. C., & Heneka, M. T. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00722-y · Cited by 158
Inflammatory pathways in Alzheimer’s disease mediated by gut microbiota
Qian, X.-H., Song, X.-X., Liu, X.-L., Chen, S.-D., & Tang, H.-D. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101317 · Cited by 153
Kim, H. S., Kim, S., Shin, S. J., Park, Y. H., Nam, Y., Kim, C. W., Lee, K. W., Kim, S.-M., Jung, I. D., Yang, H. D., et al. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-021-00273-y · Cited by 148
Zhou, M., Lv, J., Chen, X., Shi, Y., Chao, G., & Zhang, S. (2025) · Annals of Hepatology · doi:10.1016/j.aohep.2025.101777 · Cited by 111
Das, T. K., & Ganesh, B. P. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2206504 · Cited by 109
Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside
Ma, Y., Li, X., Yu, J., & Wang, Y. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00404-1 · Cited by 105
The Link between Obesity, Microbiota Dysbiosis, and Neurodegenerative Pathogenesis
Vamanu, E., & Nand, S. (2021) · Diseases · doi:10.3390/diseases9030045 · Cited by 96
The Endotoxin Hypothesis of Parkinson's Disease
Brown, G. C., Camacho, M., & Williams‐Gray, C. H. (2023) · Movement Disorders · doi:10.1002/mds.29432 · Cited by 90
Varesi, A., Campagnoli, L. I. M., Fahmideh, F., Pierella, E., Romeo, M., Ricevuti, G., Nicoletta, M., Chirumbolo, S., & Pascale, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012289 · Cited by 88
Koszewicz, M. A., Jaroch, J., Brzecka, A., Ejma, M., Budrewicz, S. P., Михалева, Л. М., Muresanu, C., Schield, P., Somasundaram, S. G., Kirkland, C. E., et al. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105277 · Cited by 88
Shabbir, U., Tyagi, A., Elahi, F., Aloo, S. O., & Oh, D. (2021) · Antioxidants · doi:10.3390/antiox10091370 · Cited by 81
Implications of gut and oral microbiota in neuroinflammatory responses in Alzheimer's disease
Bello-Corral, L., Gomes, L., Fernández-Fernández, J. A., Fernández-García, D., Verdejo, I. C., & Sánchez-Valdeón, L. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122132 · Cited by 79
Zheng, D., Liao, H., Chen, S., Liu, X., Mao, C., Zhang, C., Meng, M., Wang, Z., Wang, Y., Jiang, Q., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.796212 · Cited by 66
Gut microbiota metabolites, redox status, and the related regulatory effects of probiotics
Zhao, J.-S., Zhao, F., Yuan, J., Liu, H., & Wang, Y. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e21431 · Cited by 58
Prato, A., Gulisano, M., Scerbo, M., Barone, R. M. E., Vicario, C. M., & Rizzo, R. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.746639 · Cited by 58
Yu, H., Sun, T., He, X., Wang, Z., Zhao, K., An, J., Wen, L., Li, J., Li, W., & Feng, J. (2022) · Aging and Disease · doi:10.14336/ad.2022.0325 · Cited by 57
Xiong, S. Y., Su, X., Kang, Y., Si, J., Wang, L., Li, X., & Ma, K. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1178188 · Cited by 54
Chen, S., Zhang, P., Duan, H., Wang, J., Qiu, Y., Cui, Z., Yin, Y., Wan, D., & Xie, L. (2023) · The Innovation · doi:10.1016/j.xinn.2023.100479 · Cited by 53
Lista, S., Munafò, A., Caraci, F., Imbimbo, C., Emanuele, E., Minoretti, P., Pinto-Fraga, J., Merino-País, M., Crespo‐Escobar, P., López‐Ortiz, S., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102659 · Cited by 51
Neurodegenerative Microbially-Shaped Diseases: Oxidative Stress Meets Neuroinflammation
Silva, D. F., Empadinhas, N., Cardoso, S. M., & Esteves, A. R. (2022) · Antioxidants · doi:10.3390/antiox11112141 · Cited by 47
Zhou, R., Chen, S., Zhao, Z., Tu, D., Song, S., Wang, Y., Wang, Q., Feng, J., & Hong, J. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03393-w · Cited by 46
López‐Pingarrón, L., Almeida, H., Soria-Aznar, M., Reyes-Gonzales, M. C., Rodríguez-Moratinos, A. B., Muñoz‐Hoyos, A., & García, J. J. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45040232 · Cited by 44
Sancandi, M., Uysal-Onganer, P., Kraev, I., Mercer, A., & Lange, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082743 · Cited by 41
“Roles for the gut microbiota in neuroinflammation has also been hypothesised and assessed for other neurodegenerative diseases, including AD and amyotrophic lateral sclerosis (ALS) [73].”
BackgroundInfluentialMahapatra, C., Thakkar, R., & Kumar, R. (2024) · Antioxidants · doi:10.3390/antiox13101172 · Cited by 40
Pathophysiological Links Between Obesity and Dementia
Zhang, D. E. W., Tran, V., Vinh, A., Dinh, Q. N., Drummond, G. R., Sobey, C. G., Jelinic, M., & Silva, T. M. D. (2023) · NeuroMolecular Medicine · doi:10.1007/s12017-023-08746-1 · Cited by 40
Translocation of bacteria from the gut to the brain in mice
Thapa, M., Kumari, A. R., Chin, C., Choby, J. E., Akbari, E., Bogati, B., Jin, F., Furr, E., Chopyk, D. M., Koduri, N., et al. (2026) · PLoS Biology · doi:10.1371/journal.pbio.3003652 · Cited by 40
NOX2 Activation in COVID-19: Possible Implications for Neurodegenerative Diseases
Sindona, C., Schepici, G., Contestabile, V., Bramanti, P., & Mazzon, E. (2021) · Medicina · doi:10.3390/medicina57060604 · Cited by 36
Choroszy, M., Sobieszczańska, B., Litwinowicz, K., Łaczmański, Ł., Chmielarz, M., Walczuk, U., Roleder, T., Radziejewska, J., & Wawrzyńska, M. (2022) · Nutrients · doi:10.3390/nu14030424 · Cited by 33
Casani-Cubel, J., Benlloch, M., Sanchis-Sanchis, C. E., Marín, R., Lajara-Romance, J. M., & Ortí, J. E. D. L. R. (2021) · Metabolites · doi:10.3390/metabo11020120 · Cited by 33
Botchway, B. O., Okoye, F. C., Chen, Y., Arthur, W. E., & Fang, M. (2022) · Aging and disease · doi:10.14336/ad.2021.0616 · Cited by 32
Massussi, M., Bellicini, M. G., Adamo, M., Pilotto, A., Metra, M., Padovani, A., & Proietti, R. (2024) · ESC Heart Failure · doi:10.1002/ehf2.15144 · Cited by 28
The Role of Bacteria-Derived Hydrogen Sulfide in Multiple Axes of Disease
Birg, A., & Lin, H. C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073340 · Cited by 26
Matatall, K. A., Wathan, T. K., Nguyen, M., Chen, H., McDonald, A., Qi, G., Belk, J. A., Florez, M. A., Le, D. T., Olarinde, T., et al. (2025) · Cell Stem Cell · doi:10.1016/j.stem.2025.06.006 · Cited by 23
How leaky is the gut in Parkinson’s disease?
Derkinderen, P., Cossais, F., Kulcsárová, K., Škorvánek, M., Montaigne, L. S., Coron, E., Leclair‐Visonneau, L., Cerri, S., Pellegrini, C., & Rolli‐Derkinderen, M. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105796 · Cited by 24
Role of the gut microbiome in Alzheimer’s disease
Chok, K. C., Ng, K. Y., Koh, R. Y., & Chye, S. M. (2021) · Reviews in the Neurosciences · doi:10.1515/revneuro-2020-0122 · Cited by 23
Loffredo, L., Spalice, A., Salvatori, F., Castro, G. D., Guido, C. A., Zicari, A. M., Ciacci, P., Battaglia, S., Brindisi, G., Ettorre, E., et al. (2020) · BMC Pediatrics · doi:10.1186/s12887-020-02026-8 · Cited by 23
Self-citationHan, Y., Lu, Y. Y., Li, X., Niu, X., Chang, A. K., Yang, Z., Li, X., He, X., & Bi, X. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108377 · Cited by 22
Mercado, G., Käufer, C., Richter, F., & Peelaerts, W. (2024) · Journal of Parkinson s Disease · doi:10.3233/jpd-240195 · Cited by 20
NOX2 in Alzheimer's and Parkinson's disease
Dustin, C. M., Shiva, S. S., Vazquez, A. L., Saeed, A., Pascoal, T. A., Cifuentes-Pagano, E., & Pagano, P. J. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103433 · Cited by 20
Zhang, J., Yang, Y., Al-Ahmady, Z. S., Du, W., Duan, J., Liao, Z., Sun, Q., Wei, Z., & Hua, J. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.114425 · Cited by 19
Meganathan, V., Hamilton, C. E., Natarajan, K., Keshava, S., & Boggaram, V. (2022) · The FASEB Journal · doi:10.1096/fj.202100732r · Cited by 18
Chandra, S., & Vassar, R. J. (2024) · Immunological Reviews · doi:10.1111/imr.13412 · Cited by 19
Low-grade endotoxemia and NOX2 in patients with coronary microvascular angina
Loffredo, L., Ivanov, V., Ciobanu, N., Ivanov, M., Ciacci, P., Nocella, C., Cammisotto, V., Orlando, F., Paraninfi, A., Maggio, E., et al. (2022) · Kardiologia Polska · doi:10.33963/kp.a2022.0130 · Cited by 18
Self-citationNishal, S., Phaugat, P., Bazaad, J., Dhaka, R., Khatkar, S., Khatkar, A., Khayatkashani, M., Alizadeh, P., Haghighi, S. M., Mehri, M., et al. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220614110616 · Cited by 18
Obesity and the nervous system
Антонова, К. В., Tanashyan, M. М., Раскуражев, А. А., Спрышков, Н. Е., Панина, А. А., Лагода, О. В., As, A., & Troshina, E. A. (2024) · Obesity and metabolism · doi:10.14341/omet13019 · Cited by 17
Do Bacterial Outer Membrane Vesicles Contribute to Chronic Inflammation in Parkinson’s Disease?
Koukoulis, T. F., Beauchamp, L. C., Kaparakis‐Liaskos, M., McQuade, R. M., Purnianto, A., Finkelstein, D. I., Barnham, K. J., & Vella, L. J. (2024) · Journal of Parkinson s Disease · doi:10.3233/jpd-230315 · Cited by 16
Altered cognitive function in obese patients: relationship to gut flora
Deng, M., Tang, F., & Zhu, Z. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-05201-y · Cited by 16
Loffredo, L., Alfano, A. R., Ettorre, E., Desideri, G., Carnevale, R., Forte, M., Maglione, V., Bartimoccia, S., Castellani, V., Totè, C. M., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251345157 · Cited by 16
Self-citationManole, E., Dumitrescu, L., Niculite, C. M., Popescu, B. O., & Ceafalan, L. C. (2021) · Biocell · doi:10.32604/biocell.2021.013452 · Cited by 15
Ciacci, P., Paraninfi, A., Orlando, F., Rella, S., Maggio, E., Oliva, A., Cangemi, R., Carnevale, R., Bartimoccia, S., Cammisotto, V., et al. (2023) · Microvascular Research · doi:10.1016/j.mvr.2023.104557 · Cited by 14
Self-citationBarbalace, M. C., Freschi, M., Rinaldi, I., Zallocco, L., Malaguti, M., Manera, C., Ortore, G., Zuccarini, M., Ronci, M., Cuffaro, D., et al. (2024) · Antioxidants · doi:10.3390/antiox13091074 · Cited by 13
Chen, P.-C., Yu, C.-C., Chen, Y., Lu, C.-H., Chan, S.-H., Chou, K., Chen, M., Chen, M., & Lin, W. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/3666327 · Cited by 13
Wu, X. O., Ji, D., Wang, Z., Yu, W., Du, Q., Hu, W., Zheng, Y., Dong, X., & Chen, F. (2023) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s407907 · Cited by 12
Liu, X., Yang, K., Jia, Y., Yeertai, Y., Wu, C., Wang, X., Jia, Q., Gu, Z., Cong, J., & Ling, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1549554 · Cited by 11
Liu, H., Yan, X.-J., Hu, J., Hu, P., Mao, X. O., & Cheng, Y. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111527 · Cited by 12
Microbiota and Alzheimer’s disease: mechanistic insights from a multi-organ perspective
Liao, J., Mou, H., Luo, S., Shen, L., & Jiao, B. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00541-9 · Cited by 11
Bressa, C., González-Soltero, R., Tabone, M., Clemente-Velasco, S., Gálvez, B. G., & Larrosa, M. (2025) · AMB Express · doi:10.1186/s13568-025-01888-4 · Cited by 10
De, S., Banerjee, S., Rakshit, P., Banerjee, S., & Kumar, S. K. A. (2024) · Current Diabetes Reviews · doi:10.2174/0115733998291968240429111357 · Cited by 9
Bagnato, C., Magna, A., Mereu, E., Bernardini, S., Bartimoccia, S., Marti, R., Lazzerini, P. E., D’Amico, A., Ettorre, E., Desideri, G., et al. (2025) · Antioxidants · doi:10.3390/antiox14030304 · Cited by 9
Self-citationCornò, M. D., Aureli, A., Varano, B., & Conti, L. (2026) · Biomolecules · doi:10.3390/biom16020226 · Cited by 8
Gong, Y., Luo, H., Li, Z., Feng, Y., Liu, Z., & Chang, J. (2023) · Metabolites · doi:10.3390/metabo13080954 · Cited by 7
Zeamer, A. L., Lai, Y., Loew, E. B., Sanborn, V. E., Tracy, M., Jo, C., Ferdinand, D., Ward, D. V., Bhattarai, S. K., Drake, J., et al. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2676162 · Cited by 6
Nanocarriers to mediate the pathways from diabetes toward Parkinson's disease
De, S., & Kuo, Y. (2024) · Journal of the Taiwan Institute of Chemical Engineers · doi:10.1016/j.jtice.2024.105401 · Cited by 6
Shajahan, S. R., Hamid, N., Okunsai, B., Shari, N. B., & Ramli, M. D. C. (2026) · Biomedicines · doi:10.3390/biomedicines14040860 · Cited by 5
The silent saboteur: oxidative stress and the path to cognitive dysfunction
Garcia, T. F. M., Desio, J. A. F., de Souza, E. F., Henkes, S. F. C., Santos, L. S., Muenho, J. D. C., Gonçalves, C. L., & dos Santos, J. C. C. (2025) · Neurodegenerative Disease Management · doi:10.1080/17582024.2025.2510175 · Cited by 5
Microbial Trojan Horses: Virulence Factors as Key Players in Neurodegenerative Diseases
Grahl, M. V. C., Hohl, K. S., Smaniotto, T. Â., & Carlini, C. R. (2025) · Molecules · doi:10.3390/molecules30030687 · Cited by 5
Г.Т., Т., Zholdassova, M., Novosolova, N., Malm, T., Giniatullin, R. A., & Kustubayeva, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms27010369 · Cited by 5
Serum Zonulin Levels in Pediatric Migraine
Tuncer, G. Ö., Akbaş, Y., Köker, A., Köker, S. A., Kara, T. T., Çoban, Y., & Kömüroğlu, A. U. (2023) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2023.04.014 · Cited by 3
Kim, H., & Kim, S. (2024) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2024.106631 · Cited by 3
Totè, C. M., Capponi, M., Salvatori, F., Zicari, A. M., Guido, C. A., Brindisi, G., Iantorno, L., Bartimoccia, S., Baratta, F., Forte, M., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136336 · Cited by 3
Self-citationSteinacker, J. M., van Mechelen, W., Engebretsen, L., Verhagen, E. A. L. M., Börjesson, M., González‐Gross, M., Hutchinson, M. R., Zupet, P., Löllgen, H., van Rensburg, D. C. J., et al. (2026) · Sports Medicine · doi:10.1007/s40279-026-02495-4 · Cited by 2
Self-citationWormser, U., Sintov, A. C., Vinceti, M., Mandrioli, J., Brodsky, B., Proscura, E., & Finkelstein, Y. (2023) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2023.00060 · Cited by 2
Inositol Hexaphosphate as an Inhibitor and Potential Regulator of p47phox Membrane Anchoring
Develin, A. M., & Fuglestad, B. (2024) · Biochemistry · doi:10.1021/acs.biochem.4c00117 · Cited by 2
Obesity's cognitive consequences: leptin's influence on dementia
Kara, E., & Işıklı, Ş. (2024) · Journal of Health Sciences and Medicine · doi:10.32322/jhsm.1462938 · Cited by 2
Goldansaz, S. A., Hailemariam, D., Dervishi, E., Zwierzchowski, G., Wójcik, R., Wishart, D. S., & Ametaj, B. N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136245 · Cited by 2
Blood zonulin levels in restless legs syndrome: insights into intestinal permeability
Darol, E. S., Şahin, E. Ö., Sayan, S., & Alemdar, M. (2025) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.20241870 · Cited by 2
Effects of stroke on the intestinal biota in diabetic mice and type 2 diabetic patient biota
Qiao, S., Bu, S., & Wang, H. (2024) · Journal of Applied Microbiology · doi:10.1093/jambio/lxae015 · Cited by 1
The Link Between Periodontal Disease and Alzheimer's Disease: a narrative review
Gęborys, K., Burzykowska, K., Trela, K., Więcko, L., Tuteja, A., Olczyk, L., & Podleśna, D. (2025) · Quality in Sport · doi:10.12775/qs.2025.41.60400 · Cited by 1
PTH-driven modulation of platelet activity via the NOX2 pathway in postsurgical hypoparathyroidism
D’Amico, A., Tabacco, G., Nocella, C., Naciu, A. M., Nusca, A., Piccirillo, F., Viscusi, M. M., Bernardini, F., Valenti, V., Leonardo, A., et al. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103896 · Cited by 1
Self-citationResearch progress on the role of gut microbiota in skeletal muscle atrophy
Wen-Ya, G. U. O., XIANG, S.-J., ZHANG, X.-L., Yao, L., & Li, Y. (2026) · Shengming kexue · doi:10.3724/cbls.2026011 · Cited by 1
Revisiting the NETs-CYBB-p38 MAPK axis in bronchiectasis: The underlying oxidative injury mechanism
Zheng, S., Tang, J., Wu, X., Qing, C., Jiang, Y., Lü, W., Bao, C., Hong, K., Luo, J., & Kong, J. (2026) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2026.168236 · Cited by 1
Kong, Y., Lv, X., Yang, Y., Li, Q., Dai, C., Lin, X., Liu, J., & Li, J. (2026) · Journal of Integrative Neuroscience · doi:10.31083/jin48598 · Cited by 1
Popovici, M., Loffredo, L., Ivanov, V., Popovici, I., Ciobanu, L., Munteanu, M., Popovici, I., & Cobeţ, V. (2023) · Bulletin of the Academy of Sciences of Moldova Medical Sciences · doi:10.52692/1857-0011.2023.1-75.01
Self-citationOxisteróis e sua relação com a neuroinflamação na esclerose lateral amiotrófica
Lima, R. S. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.46.2023.tde-12122023-105206
Structural basis of anaphylatoxin receptor activation and signaling bias
Yadav, R., Yadav, M. K., Maharana, J., Saha, S., Sarma, P., Banerjee, R., Shukla, A. K., & Gati, C. (2024) · Biophysical Journal · doi:10.1016/j.bpj.2023.11.240
Zhu, H., Deuser, J. T., Stern, T., & O’Shaughnessy, B. (2024) · Biophysical Journal · doi:10.1016/j.bpj.2023.11.3330
Alarcón‐Romero, L. D. C., Zubillaga‐Guerrero, M. I., William, C. I. M., Illades‐Aguiar, B., García, A. M. E., Rivera, M. J. M., Barrera, J. A. P., Gómez‐Gómez, Y., & Hernández, M. V. (2024) · doi:10.22533/at.ed.8022401044
A CONEXÃO CURIOSA ENTRE DIABETES MELLITUS E A DOENÇA DE PARKINSON
Maciel, L. M., dos Santos, A. V. F., da Silva, C. V. B. G., dos Santos, G. L. G., Galdino, E. D. S., de Moraes, J. G. F., Miranda, M. A., Silva, M. A. P. D. C. C., Barbosa, J. O. L., & de Lira, A. C. L. (2024) · doi:10.22533/at.ed.8022401047
FATORES QUE INFLUENCIAM NA PREMATURIDADE
Carneiro, C. R. D. N., Reis, C. C. C., Dias, R. A., Sales, E. Q., Ferreira, T. P. A., Silva, P. S. L. E., Costa, P. N., Soares, J. B., Reis, M. C. P., Fernandes, L., et al. (2024) · doi:10.22533/at.ed.8022401043
de Freitas, S. S., Alves, J. D. L., da Silva, W. L. S., Paulino, B. D. S., Prado, N. S., de Arruda, M. A., Amancio, S. R. F., de Barros, C. F. E., Bezerra, A. M. F. D. A., de Souza, F. R., et al. (2024) · doi:10.22533/at.ed.8022401046
IMUNOLÓGICOS ENVOLVIDOS NA PATOGÊNESE DA DOENÇA PERIODONTAL
Freire, J. M. D. O., Sousa, L. M. V. L., Rodrigues, Í. A., de Sousa, B. S., de Menezes, R. L. R., Nascimento, A. L. S., de Oliveira, M. M., & da Costa, I. B. (2024) · doi:10.22533/at.ed.8022401042
CUIDADOS PALIATIVOS NEONATAIS PARA A FAMÍLIA
Silva, F. A., Chady, C. S., & Dias, R. A. (2024) · doi:10.22533/at.ed.8022401045
USO DE PSICOTRÓPICOS EN CULTURAS ANCESTRALES: UN VIAJE A TRAVÉS DEL TIEMPO Y LAS TRADICIONES
de Aparicio, C. X. P., Guerrero, D. A. H., & Pazmiño, P. V. L. (2024) · doi:10.22533/at.ed.8022401041
Ngadena, Y. S. M., Owona, P. E., Ella, F. A., Bilanda, D. C., Yandja, P. C. B., Bindzi, G. M., & Dzeufiet, P. D. D. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5066541
Su, C., Shen, D., Xu, J., Chen, M., He, H., & Ye, J. (2025) · Brain and Behavior · doi:10.1002/brb3.70692
Trares, K. (2023) · heiDOK (Heidelberg University) · doi:10.11588/heidok.00032858
Camacho, M. (2024) · Apollo (University of Cambridge) · doi:10.17863/cam.108869
Metadata
- Authors
- Loffredo, L., Ettorre, E., Zicari, A. M., Inghilleri, M., Nocella, C., Perri, L., Spalice, A., Fossati, C., De Lucia, M. C., Pigozzi, F., Cacciafesta, M., Violi, F., Carnevale, R., & Neurodegenerative Disease study group
- Affiliations
- Sapienza University of Rome (IT)
- Clinica Mediterranea (IT)
- Foro Italico University of Rome (IT)
- UTNA, IRCCS Neuromed Pozzilli, Isernia, Italy
- Corresponding author
- Loffredo, Lorenzo
- ORCID
- Venue
- Oxidative Medicine and Cellular Longevity
- Publisher
- Wiley
- Published
- 2020-02-01
- Volume
- 2020
- Pages
- 1-7
- ISSN
- 1942-0994 (ISSN-L)
- 1942-0900
- PMC
- PMC7016401
- OpenAlex
- W3004090161
- Cited by
- 100
- References
- 40
- Citations by year
- 2026: 12 · 2025: 21 · 2024: 24 · 2023: 16 · 2022: 10 · 2021: 12 · 2020: 5
- FWCI
- 3.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Oxidative Medicine and Cellular Longevity (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion, cc-by-sa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- University of Rome “La Sapienza” (RMC26A1183Z8)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Keywords
- neurodegenerative diseases, NADPH oxidase 2, oxidative stress, lipopolysaccharide, gut microbiota, neuroinflammation, 8-isoprostane, hydrogen peroxide, zonulin, intestinal permeability, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, biomarkers
- MeSH terms
- NADPH Oxidase 2, Aged, Female, Humans, Lipopolysaccharides, Male, Oxidative Stress, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
